Cargando…
Inhibition of monoamine oxidase B reduces atherosclerosis and fatty liver in mice
Oxidative stress is vital for pathophysiology of atherosclerosis and non-alcoholic fatty liver disease (NAFLD). Monoamine oxidase (MAO) is an important source of oxidative stress in the vascular system and liver. However, the effect of MAO inhibition on atherosclerosis and NAFLD has not been explore...
Autores principales: | Wang, Shu-Huei, Tsai, Feng-Chiao, Lin, Heng-Huei, Yu, Tse-Ya, Kuo, Chun-Heng, Li, Hung-Yuan, Lin, Mao-Shin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810528/ https://www.ncbi.nlm.nih.gov/pubmed/36416117 http://dx.doi.org/10.1042/CS20220477 |
Ejemplares similares
-
Decoding microRNA drivers in atherosclerosis
por: Vartak, Tanwi, et al.
Publicado: (2022) -
Diabetic atherosclerosis: is there a role for the hypoxia-inducible factors?
por: Pirri, Daniela, et al.
Publicado: (2020) -
Potential role of perivascular adipose tissue in modulating atherosclerosis
por: Ahmadieh, Samah, et al.
Publicado: (2020) -
Andrographolide in atherosclerosis: integrating network pharmacology and in vitro pharmacological evaluation
por: Shi, Shuai, et al.
Publicado: (2022) -
Translating atherosclerosis research from bench to bedside: navigating the barriers for effective preclinical drug discovery
por: May, Lauren T., et al.
Publicado: (2022)